Insomnia

Curriculums that paired several podcast episodes with case-based classroom discussions improved preparation and knowledge on menopause among OB/GYN, family medicine and internal medicine specialists, researchers reported in Menopause.

The Alaska Department of Health recently reported the first death from Alaskapox, an orthopoxvirus that can be transmitted from animals to humans.

Melatonin is one of the most popular and easily accessible supplements today.

More than three-quarters of people with mild COVID-19 reported experiencing insomnia after recovery, and it was more common among those with anxiety or depression, according to the results of a survey.

A Sudarshan Kriya Yoga online program led to significant improvements in wellness and decreased burnout among a cohort of international physicians, according to study results published in JAMA Network Open.

A behavioral economics intervention was associated with reduced low-value care among older adults, according to a randomized study published in JAMA Internal Medicine.

There was no difference in for adults on hemodialysis with mild or moderate chronic insomnia, recently published data.

Combination behavioral and pharmaceutical therapy improved functionality and daytime symptoms of insomnia, while addition of a second treatment provided further benefits for the condition, according to research from JAMA Network Open.

Healio Pulmonology has compiled the top news on sleep disorders posted in 2023.

The U.S. Patent and Trademark Office has issued a patent expanding existing protections for ANAVEX2-73, a drug potentially effective in Alzheimer’s disease, according to a press release from the manufacturer.